Health organizations using AI to accelerate digital tool development must still complete standard privacy, security, and procurement reviews. While AI can speed up coding, it does not automate the necessary governance documentation. Custodians remain accountable for personal health information regardless of the development method used.
Before adopting AI-built tools, confirm with vendors that they use enterprise agreements with zero data retention and only synthetic data in development environments.
The manufacturer identified a software issue affecting all RotaFlow consoles on the market. This fault can prevent the device from charging its battery after the unit has operated in battery mode. Users should contact the manufacturer for further information regarding this device defect.
If you use RotaFlow consoles in your clinical practice, contact the manufacturer to determine how this charging issue affects your equipment's reliability.
The Pan-Canadian Pharmaceutical Alliance and the manufacturer of Elahere have reached a funding agreement. This targeted chemotherapy for FRα-positive, platinum-resistant ovarian cancer is now recommended for public reimbursement by Canada’s Drug Agency. Provincial and territorial governments must now finalize the process to include the drug in their respective public plans.
If you treat patients with platinum-resistant ovarian cancer, this agreement moves the drug closer to being covered by provincial public drug plans.
Abbott has released a mandatory security update for the FreeStyle Libre 3 app on Android and iOS. A previous patch to address a vulnerability caused a defect that may lead to prolonged communication loss between the app and the sensor. Users must update to version 3.6.10 immediately to resolve this issue.
If you assist patients using this system, ensure they update their app to version 3.6.10 to prevent sensor connection failures.
Medtronic has issued a recall to update the instructions for use for the Abre venous self-expanding stent system. The update provides a validated manual deployment method to address rare instances of partial stent deployment. No product returns or disposals are required.
If you use this device, review the new manual deployment instructions provided by the manufacturer to manage potential partial stent deployment.
Moderna and Merck's personalized mRNA vaccine intismeran cut the risk of melanoma returning by 42 per cent two years after surgery, in a study of more than 1,100 people with high-risk melanoma. Two years on, 82 per cent of vaccinated patients were recurrence-free, versus 70 per cent on Keytruda alone. The companies are discussing approval with regulators; full results were due at a European oncology meeting in Madrid.
A personalized mRNA vaccine, matched to each patient's tumour, is moving toward approval after a large trial showed a clear gain in living without recurrence.
Saskatchewan hospitals are now using a rapid test that gives a mother with HIV her viral load on site within about two hours, instead of waiting days for a central lab, so treatment decisions for mother and newborn can be made at once. The practice is in use in Regina and Saskatoon and is rolling out to Melfort and more remote communities. Saskatchewan is the first province to use the test this widely; in 2024 its first-time HIV diagnosis rate was three times the national average, second only to Manitoba.
A two-hour result instead of days means treatment for mother and baby can start before they leave the hospital.
Abbott has issued a recall for specific lots of i-STAT hs-TnI cartridges due to manufacturing variability. These cartridges may produce falsely elevated cardiac troponin I results because of reduced interference mitigation. There is no evidence of falsely low test results.
Check your i-STAT hs-TnI cartridge lots against the recall list and stop using any affected units immediately.
A study involving Manitoba researchers found that the time taken to start appropriate antifungal therapy is the most significant factor for survival in Candida septic shock. Patients treated within two hours of persistent hypotension had an 86% survival rate, with outcomes worsening by 5% for every hour of delay thereafter.
For patients with suspected Candida septic shock, prioritizing the rapid administration of appropriate antifungal therapy within the first two hours of hypotension is critical.
Federal, provincial, and territorial health ministers met in Winnipeg on October 16, 2026, to discuss healthcare system reforms. Key priorities included improving workforce mobility for internationally educated professionals, advancing national public health data sharing, and ensuring the sustainability of long-term funding for rare disease treatments and community care services.
